SE8101205L - Nya iminiumsalter och forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on - Google Patents

Nya iminiumsalter och forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Info

Publication number
SE8101205L
SE8101205L SE8101205A SE8101205A SE8101205L SE 8101205 L SE8101205 L SE 8101205L SE 8101205 A SE8101205 A SE 8101205A SE 8101205 A SE8101205 A SE 8101205A SE 8101205 L SE8101205 L SE 8101205L
Authority
SE
Sweden
Prior art keywords
carbamyl
cyano
bipyridine
procedures
preparation
Prior art date
Application number
SE8101205A
Other languages
English (en)
Other versions
SE437514B (sv
Inventor
K O Gelotte
Jr C J Opalka
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of SE8101205L publication Critical patent/SE8101205L/sv
Publication of SE437514B publication Critical patent/SE437514B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8101205A 1980-02-26 1981-02-24 N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten SE437514B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/124,808 US4264609A (en) 1980-02-26 1980-02-26 N-[3-Dimethylamino-2-(4-pyridinyl)-2-propenylidene]-N-methylmethaniminium chloride hydrochloride, its use in preparing 5-(cyano or carbamyl)-[3,4'-bipyridin]-6(1H)-one and its use as a cardiotonic

Publications (2)

Publication Number Publication Date
SE8101205L true SE8101205L (sv) 1981-08-27
SE437514B SE437514B (sv) 1985-03-04

Family

ID=22416880

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8101205A SE437514B (sv) 1980-02-26 1981-02-24 N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten
SE8402727A SE452764B (sv) 1980-02-26 1984-05-21 Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8402727A SE452764B (sv) 1980-02-26 1984-05-21 Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Country Status (28)

Country Link
US (1) US4264609A (sv)
JP (1) JPS56128758A (sv)
KR (2) KR840002067B1 (sv)
AR (1) AR230630A1 (sv)
AT (2) AT380237B (sv)
AU (1) AU541644B2 (sv)
BE (1) BE887663A (sv)
CA (1) CA1128523A (sv)
CH (1) CH647509A5 (sv)
DE (1) DE3107306A1 (sv)
DK (1) DK171253B1 (sv)
ES (1) ES499776A1 (sv)
FI (1) FI76787C (sv)
FR (1) FR2476646A1 (sv)
GB (1) GB2070600B (sv)
HK (1) HK71789A (sv)
IE (1) IE51696B1 (sv)
IL (1) IL62161A (sv)
IT (1) IT1210992B (sv)
LU (1) LU83169A1 (sv)
MX (1) MX6908E (sv)
NL (1) NL192109C (sv)
NO (1) NO156689C (sv)
NZ (1) NZ196282A (sv)
PH (2) PH19904A (sv)
PT (1) PT72573B (sv)
SE (2) SE437514B (sv)
ZA (1) ZA811124B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3685840D1 (de) 1985-04-30 1992-08-06 Dresden Arzneimittel 3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
JPH0141626B2 (sv) 1989-09-06
PH17145A (en) 1984-06-04
ATA305683A (de) 1985-09-15
PT72573A (pt) 1981-03-01
IL62161A (en) 1984-06-29
DK83981A (da) 1981-08-27
SE437514B (sv) 1985-03-04
SE8402727D0 (sv) 1984-05-21
IE810397L (en) 1981-08-26
NL192109B (nl) 1996-10-01
PT72573B (en) 1982-02-12
FI810582L (fi) 1981-08-27
DE3107306C2 (sv) 1990-11-29
GB2070600B (en) 1984-07-11
IT8119952A0 (it) 1981-02-24
AT380237B (de) 1986-04-25
SE452764B (sv) 1987-12-14
AU541644B2 (en) 1985-01-17
KR840002067B1 (ko) 1984-11-09
FR2476646B1 (sv) 1984-08-17
IE51696B1 (en) 1987-02-18
ZA811124B (en) 1982-03-31
IT1210992B (it) 1989-09-29
MX6908E (es) 1986-11-07
SE8402727L (sv) 1984-05-21
AU6748781A (en) 1981-09-03
NL8100922A (nl) 1981-09-16
US4264609A (en) 1981-04-28
HK71789A (en) 1989-09-14
FR2476646A1 (fr) 1981-08-28
AT380236B (de) 1986-04-25
PH19904A (en) 1986-08-13
NO810639L (no) 1981-08-27
AR230630A1 (es) 1984-05-31
GB2070600A (en) 1981-09-09
CA1128523A (en) 1982-07-27
FI76787B (fi) 1988-08-31
NL192109C (nl) 1997-02-04
NO156689C (no) 1987-11-04
BE887663A (fr) 1981-08-25
KR840002066B1 (ko) 1984-11-09
NO156689B (no) 1987-07-27
IL62161A0 (en) 1981-03-31
FI76787C (sv) 1988-12-12
ES499776A1 (es) 1984-06-16
KR830005143A (ko) 1983-08-03
ATA88581A (de) 1985-09-15
LU83169A1 (fr) 1981-09-11
JPS56128758A (en) 1981-10-08
NZ196282A (en) 1983-12-16
DK171253B1 (da) 1996-08-12
DE3107306A1 (de) 1981-12-17
CH647509A5 (fr) 1985-01-31

Similar Documents

Publication Publication Date Title
ES2300151T3 (es) Derivados de cianofenilo.
ES2325461T3 (es) Inhibidores de pirrolotriazina cinasa.
ES2342240T3 (es) Derivados de isoquinolina con actividad que inhibe la angiogenia.
JP7305196B2 (ja) ハロアリルアミン類のssao/vap-1阻害剤とその用途
ES2241781T3 (es) Derivados de piridina inhibidores de la angiogenesis y/o del receptor tirosina quinasa de vegf.
ES2324768T3 (es) 2,6-diamino-3,5-diciano-4-arilpiridinas sustituidas y su uso como ligandos selectivos de receptores de adenosina.
US7879839B2 (en) Potassium channel inhibitors
JP7219902B2 (ja) ブルトン型チロシンキナーゼ阻害剤
SE8102022L (sv) Intermediat i form av 2(ih)-pyridinoner samt forfarande for framstellning derav
EP0303697A1 (en) Derivatives of physiologically active substance k-252
IL155447A (en) Nitrogenic aromatic circular compounds
JP2008517956A (ja) 二重の抗血小板性/抗凝固性ピリドキシン類似体
JPH11269146A (ja) 分化誘導剤
SE8501169D0 (sv) Diaminopyridin-intermedierer
US10214554B2 (en) Process for making chloro-substituted nucleoside phosphoramidate compounds
US4060601A (en) Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines
US20170298070A1 (en) Novel chiral synthesis of n-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines
KR920016421A (ko) 피리딘 화합물
SE8101205L (sv) Nya iminiumsalter och forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on
ES8706151A1 (es) Un procedimiento para preparar un derivado de 1,6-naftiri- din-2(1h)-ona
JP2021530455A (ja) 三環式化合物
NO832784L (no) 5-(lavere-alkyl)-1,6-nafthyridin-2(1h)-on-forbindelser og fremgangsmaate for deres fremstilling
US4144343A (en) Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines
JP4464560B2 (ja) 置換イソインドロンおよび医薬におけるサイクリックgmp調節剤としてのそれらの使用
CN109516984A (zh) 一种2-巯基-5-氰基嘧啶类衍生物及其制备方法和应用

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8101205-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8101205-6

Format of ref document f/p: F